Efficacy of Education and MEtabolic SYndrom Screening (EMESYS) intervention on Antipsychotic Treatment for Patients with Schizophrenia

Not Applicable

Recruiting

• Conditions: Patients with schizophrenia diagnosed di; schizophrenia, antipsychotic, adherence, QoL; Qo

• Registration Number: TCTR20200116004
• Lead Sponsor: Indonesia Endowment Fund for Education

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-01-16
• Study Completion: 2021-01-24
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 55

Inclusion Criteria

1. patient schizophrenia has followed antipsychotic treatment minimum of 3 months or later
2. being adult aged 18 or older,
3. who agree to participate in the study,
4. and the patient who has insight

Exclusion Criteria

1. patient schizophrenia with mental retardation
2. patient schizophrenia with drug abuse

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
change in adherence level Baseline, 1,2 months after intervention MARS Score

Secondary Outcome Measures

Name	Time	Method
Quality of Life Baseline, 1, 2 months after intervention IM-SWN,Smoking habit Baseline, 1,2 months after intervention Number of cigarate comsumption,metabolic syndrome at 1, 2, and 3 months from the baseline BMI, laboratory screening for glucose and lipid profile